224 related articles for article (PubMed ID: 30021394)
1. Effect of Monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndrome.
Mazza A; Lenti S; Schiavon L; Di Giacomo E; Tomasi M; Manunta R; Torin G; Townsend DM; Rubello D
Biomed Pharmacother; 2018 Sep; 105():992-996. PubMed ID: 30021394
[TBL] [Abstract][Full Text] [Related]
2. The short-term supplementation of monacolin K improves the lipid and metabolic patterns of hypertensive and hypercholesterolemic subjects at low cardiovascular risk.
Mazza A; Schiavon L; Rigatelli G; Torin G; Montanaro F; Lenti S
Food Funct; 2018 Jul; 9(7):3845-3852. PubMed ID: 29951651
[TBL] [Abstract][Full Text] [Related]
3. The Effects of a New Generation of Nutraceutical Compounds on Lipid Profile and Glycaemia in Subjects with Pre-hypertension.
Mazza A; Schiavon L; Rigatelli G; Torin G; Lenti S
High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):345-350. PubMed ID: 31352663
[TBL] [Abstract][Full Text] [Related]
4. LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia.
Magno S; Ceccarini G; Pelosini C; Jaccheri R; Vitti J; Fierabracci P; Salvetti G; Airoldi G; Minale M; Saponati G; Santini F
Lipids Health Dis; 2018 May; 17(1):124. PubMed ID: 29793488
[TBL] [Abstract][Full Text] [Related]
5. Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk.
Mazza A; Lenti S; Schiavon L; Zuin M; D'Avino M; Ramazzina E; Casiglia E
Adv Ther; 2015 Jul; 32(7):680-90. PubMed ID: 26202829
[TBL] [Abstract][Full Text] [Related]
6. Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.
Simons L; Tonkon M; Masana L; Maccubbin D; Shah A; Lee M; Gumbiner B
Curr Med Res Opin; 2004 Sep; 20(9):1437-45. PubMed ID: 15383192
[TBL] [Abstract][Full Text] [Related]
7. Effects of monacolin K-containing nutraceutical on cholesterol homeostasis re-establishment and CVD risk reduction in hypercholesterolemic subjects.
Gojkovic T; Vladimirov S; Kotur-Stevuljevic J; Bogavac-Stanojevic N; Zeljkovic A; Vekic J; Antonic T; Spasojevic-Kalimanovska V
Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5261-5267. PubMed ID: 34486702
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and Safety of Novel Nutraceutical Formulation Added to Ezetimibe in Statin-Intolerant Hypercholesterolemic Subjects with Moderate-to-High Cardiovascular Risk.
Mazza A; Nicoletti M; Lenti S; Torin G; Rigatelli G; Pellizzato M; Fratter A
J Med Food; 2021 Jan; 24(1):59-66. PubMed ID: 32456525
[TBL] [Abstract][Full Text] [Related]
9. Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
Cicero AF; Derosa G; Pisciotta L; Barbagallo C;
J Med Food; 2015 Nov; 18(11):1270-3. PubMed ID: 26274827
[TBL] [Abstract][Full Text] [Related]
10. Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.
Ruscica M; Pavanello C; Gandini S; Macchi C; Botta M; Dall'Orto D; Del Puppo M; Bertolotti M; Bosisio R; Mombelli G; Sirtori CR; Calabresi L; Magni P
Nutr J; 2019 Feb; 18(1):13. PubMed ID: 30795775
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome.
Hunninghake DB; Ballantyne CM; Maccubbin DL; Shah AK; Gumbiner B; Mitchel YB
Clin Ther; 2003 Jun; 25(6):1670-86. PubMed ID: 12860491
[TBL] [Abstract][Full Text] [Related]
12. Middle-Term Dietary Supplementation with Red Yeast Rice Plus Coenzyme Q10 Improves Lipid Pattern, Endothelial Reactivity and Arterial Stiffness in Moderately Hypercholesterolemic Subjects.
Cicero AF; Morbini M; Rosticci M; D''Addato S; Grandi E; Borghi C
Ann Nutr Metab; 2016; 68(3):213-9. PubMed ID: 27055107
[TBL] [Abstract][Full Text] [Related]
13. Coenzyme Q10 supplementation improves metabolic parameters, liver function and mitochondrial respiration in rats with high doses of atorvastatin and a cholesterol-rich diet.
Jiménez-Santos MA; Juárez-Rojop IE; Tovilla-Zárate CA; Espinosa-García MT; Juárez-Oropeza MA; Ramón-Frías T; Bermúdez-Ocaña DY; Díaz-Zagoya JC
Lipids Health Dis; 2014 Jan; 13():22. PubMed ID: 24460631
[TBL] [Abstract][Full Text] [Related]
14. Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial.
Sangouni AA; Taghdir M; Mirahmadi J; Sepandi M; Parastouei K
Nutr J; 2022 Oct; 21(1):62. PubMed ID: 36192751
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.
Vigna GB; Donegà P; Zanca R; Barban A; Passaro A; Pansini F; Bonaccorsi G; Mollica G; Fellin R
Metabolism; 2002 Nov; 51(11):1463-70. PubMed ID: 12404199
[TBL] [Abstract][Full Text] [Related]
16. Relationship between adiponectin and leptin, and blood lipids in hyperlipidemia patients treated with red yeast rice.
Lee CY; Jan MS; Yu MC; Lin CC; Wei JC; Shih HC
Forsch Komplementmed; 2013; 20(3):197-203. PubMed ID: 23860021
[TBL] [Abstract][Full Text] [Related]
17. [Red yeast rice, monacolin K, and pleiotropic effects.].
Cicero AFG
Recenti Prog Med; 2018 Feb; 109(2):154e-157e. PubMed ID: 29493648
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
[TBL] [Abstract][Full Text] [Related]
19. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects.
Cicero AF; Derosa G; Parini A; Maffioli P; D'Addato S; Reggi A; Giovannini M; Borghi C
Nutr Res; 2013 Aug; 33(8):622-8. PubMed ID: 23890351
[TBL] [Abstract][Full Text] [Related]
20. Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled intervention.
Heinz T; Schuchardt JP; Möller K; Hadji P; Hahn A
Nutr Res; 2016 Oct; 36(10):1162-1170. PubMed ID: 27865358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
